Clinical Trials Browser

Combined Pituitary Hormone Deficiency, Congenital Abnormalities, Acromegaly, Gigantism, Prolactinoma, Pituitary ACTH Hypersecretion, Carcinogenesis

NCT03604198 2026-04-21

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Phase 2 Active not recruiting

125 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT04569591 2026-04-09

DDAVP for Pituitary Adenoma

Phase NA Recruiting

22 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07463625 2026-03-11

PiTFET

Recruiting

20 enrolled

Endocrine

Pituitary Diseases, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT07460232 2026-03-10

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Phase EARLY_PHASE1 Not yet recruiting

50 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT07335315 2026-01-13

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Recruiting

110 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT03364803 2025-10-23

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Recruiting

300 enrolled

Endocrine

Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT05307328 2025-10-08

RESCUE

Phase 2 Completed

26 enrolled

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT03697109 2025-07-16

GRACE

Phase 3 Completed

152 enrolled 28 charts

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Pituitary ACTH Hypersecretion

NCT05971758 2025-07-04

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

Phase 2 Recruiting

20 enrolled

Endocrine

Pituitary ACTH Hypersecretion

NCT05804669 2025-04-10

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

Phase 1/2 Recruiting

18 enrolled

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT06701838 2024-12-03

OPTIMAL

Not yet recruiting

15 enrolled

Endocrine

Cushing Syndrome, Pituitary Neoplasms, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Phase 4 Completed

337 enrolled 8 charts

DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT01915303 2020-09-18

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

Phase 2 Terminated

68 enrolled 25 charts

Endocrine

Adrenocortical Hyperfunction, Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT00612066 2020-08-06

Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

Phase 2 Terminated

2 enrolled 5 charts

Endocrine

Pituitary ACTH Hypersecretion

NCT04433819 2020-06-16

Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients

Unknown

200 enrolled

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT03474601 2020-03-18

SNU-PIT

Unknown

1,600 enrolled

Endocrine

Acromegaly, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma, Diabetes Insipidus, Neurogenic, Pituitary ACTH Hypersecretion

NCT02804750 2019-10-15

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

Phase 2 Completed

35 enrolled 13 charts

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT01582061 2018-06-19

SEASCAPE

Phase 3 Completed

104 enrolled 22 charts

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT01459237 2018-06-14

Effects of Hormone Stimulation on Brain Scans for Cushing s Disease

Phase EARLY_PHASE1 Completed

30 enrolled

Endocrine

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT00796783 2014-06-20

A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

Terminated

2 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Choristoma, Cushing Syndrome, Hirsutism, Pituitary Diseases, Pituitary ACTH Hypersecretion

NCT00936741 2014-04-02

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Phase 3 Completed

30 enrolled 8 charts

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Choristoma, Cushing Syndrome, Hirsutism, Pituitary Diseases, Pituitary ACTH Hypersecretion

NCT01371565 2014-03-18

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

Phase 3 Completed

4 enrolled 7 charts

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary Diseases, Pituitary ACTH Hypersecretion

NCT00569582 2013-08-22

SEISMIC

Phase 3 Completed

50 enrolled 8 charts

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Choristoma, Cushing Syndrome, Hirsutism, Pituitary Diseases, Pituitary ACTH Hypersecretion

NCT00889525 2009-04-29

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Phase 3 Completed

Endocrine

Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma

Clinical Trials

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

DDAVP for Pituitary Adenoma

PiTFET

FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease

Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

RESCUE

GRACE

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

OPTIMAL

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease

Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)

Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients

SNU-PIT

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

SEASCAPE

Effects of Hormone Stimulation on Brain Scans for Cushing s Disease

A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

SEISMIC

Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor